ZA836080B - Broad spectrum influenza antisera - Google Patents

Broad spectrum influenza antisera

Info

Publication number
ZA836080B
ZA836080B ZA836080A ZA836080A ZA836080B ZA 836080 B ZA836080 B ZA 836080B ZA 836080 A ZA836080 A ZA 836080A ZA 836080 A ZA836080 A ZA 836080A ZA 836080 B ZA836080 B ZA 836080B
Authority
ZA
South Africa
Prior art keywords
antisera
broad spectrum
spectrum influenza
influenza
broad
Prior art date
Application number
ZA836080A
Inventor
Nicola Green
Alexander Stephen
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of ZA836080B publication Critical patent/ZA836080B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA836080A 1982-08-23 1983-08-17 Broad spectrum influenza antisera ZA836080B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23

Publications (1)

Publication Number Publication Date
ZA836080B true ZA836080B (en) 1984-04-25

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA836080A ZA836080B (en) 1982-08-23 1983-08-17 Broad spectrum influenza antisera

Country Status (16)

Country Link
EP (1) EP0116629A4 (en)
JP (1) JPS59501714A (en)
KR (1) KR840006198A (en)
AU (1) AU570929B2 (en)
DK (1) DK203684A (en)
ES (1) ES8505819A1 (en)
FI (1) FI841583A0 (en)
GR (1) GR78931B (en)
IL (1) IL69556A (en)
IT (1) IT1168636B (en)
NO (1) NO161002C (en)
NZ (2) NZ220612A (en)
PH (1) PH18872A (en)
PT (1) PT77230B (en)
WO (1) WO1984000687A1 (en)
ZA (1) ZA836080B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (en) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Vaccinal polypeptides
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
WO1990008161A1 (en) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
EP0621339B1 (en) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Immunogenic human influenza A virus haemagglutinin polypeptides
JP2996864B2 (en) * 1994-03-30 2000-01-11 寳酒造株式会社 Antibody variable region DNA
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
AU2007249160B2 (en) * 2006-05-15 2013-09-12 I2 Pharmaceuticals, Inc. Neutralizing antibodies to influenza viruses
KR101485197B1 (en) * 2006-09-07 2015-01-23 크루셀 홀란드 비.브이. Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
ITTO20070066A1 (en) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMOTOPI ANTIGENE GP 120 DI HIV
WO2008118970A2 (en) 2007-03-27 2008-10-02 Sea Lane Biotechnologies, Llc Constructs and libraries comprising antibody surrogate light chain sequences
ITTO20080204A1 (en) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES ACTIONS TO REACT WITH A PLURALITY OF SUBTIPS OF THE INFLUENTIAL VIRUS A
US20100040635A1 (en) 2008-03-28 2010-02-18 Sea Lane Biotechnologies Neutralizing antibodies to influenza viruses
ITTO20080398A1 (en) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES HAVING PROPERTY OF HOSUBLICTIC CROSS-NEUTRALIZATION FOR INFLUENTIAL VIRUSES OF SUBTIPLE TYPE H1
ITTO20080964A1 (en) 2008-12-22 2010-06-23 Natimab Therapeutics S R L ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICATION FOR THERAPEUTIC TREATMENT AND THE PREVENTION OF HCV INFECTIONS
CN102264896B (en) 2008-12-25 2014-02-26 国立大学法人大阪大学 Human anti-human influenza virus antibody
US9051359B2 (en) 2009-03-30 2015-06-09 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
AU2010249046A1 (en) 2009-05-13 2011-12-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to influenza viruses
JP5941841B2 (en) 2009-05-26 2016-06-29 アイカーン スクール オブ メディシン アット マウント サイナイ Monoclonal antibody against influenza virus produced by periodic administration and use thereof
IT1395961B1 (en) * 2009-06-01 2012-11-02 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES AS A MEDICATION FOR THERAPEUTIC AND / OR PROFILACTIC TREATMENT OF INFLUENCIAL VIRUS INFECTIONS (H1N1) OF SWINE ORIGIN (S-OIV)
AU2011217903B2 (en) * 2010-02-18 2017-03-02 Mount Sinai School Of Medicine Vaccines for use in the prophylaxis and treatment of influenza virus disease
EP3248615A1 (en) 2010-03-30 2017-11-29 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
WO2013016714A1 (en) 2011-07-28 2013-01-31 Sea Lane Biotechnologies Sur-binding proteins against erbb3
ES2953393T3 (en) 2011-09-20 2023-11-10 Icahn School Med Mount Sinai Influenza virus vaccines and their uses
EP3446707A1 (en) 2011-12-22 2019-02-27 i2 Pharmaceuticals, Inc. Surrogate binding proteins
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
WO2014099931A1 (en) 2012-12-18 2014-06-26 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
US10513553B2 (en) 2015-11-13 2019-12-24 Visterra, Inc. Compositions and methods for treating and preventing influenza
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
CN113924147A (en) 2019-03-25 2022-01-11 威特拉公司 Compositions and methods for treating and preventing influenza

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom

Also Published As

Publication number Publication date
AU1947183A (en) 1984-03-07
WO1984000687A1 (en) 1984-03-01
GR78931B (en) 1984-10-02
NO161002B (en) 1989-03-13
AU570929B2 (en) 1988-03-31
DK203684D0 (en) 1984-04-18
ES525088A0 (en) 1985-06-16
FI841583A (en) 1984-04-19
PT77230B (en) 1986-02-04
IT1168636B (en) 1987-05-20
NO841540L (en) 1984-04-17
NO161002C (en) 1989-06-21
PT77230A (en) 1983-09-01
PH18872A (en) 1985-10-21
EP0116629A4 (en) 1987-06-29
IT8348868A0 (en) 1983-08-22
FI841583A0 (en) 1984-04-19
NZ205341A (en) 1988-07-28
IL69556A0 (en) 1983-11-30
JPS59501714A (en) 1984-10-11
DK203684A (en) 1984-04-18
NZ220612A (en) 1988-07-28
EP0116629A1 (en) 1984-08-29
KR840006198A (en) 1984-11-22
IL69556A (en) 1988-05-31
ES8505819A1 (en) 1985-06-16

Similar Documents

Publication Publication Date Title
PH18872A (en) Broad spectrum influenza antisera
JPS57109376A (en) High power mosfet
JPS56141069A (en) Generator
GB8529829D0 (en) Backsurging well
GB8316310D0 (en) Turbine
GB8324054D0 (en) Rotors
JPS5787598A (en) High performance
DE3167814D1 (en) Oil-cooled generator
JPS56150959A (en) Generator
GB2118237B (en) Ladder
GB2086759B (en) Tower packing elements
GB2089679B (en) Tower packing elements
JPS5787795A (en) Rotor plane
GB8308327D0 (en) Generator
CS108283A2 (en) Rizeni kloubu ctyrnapravovych kolejovych vozidel, zejmena vozu mestske dopravy
JPS5786047A (en) Peak spectrum generator/processor
GB8318694D0 (en) Ladder
JPS578301A (en) Rotary turbine
JPS5787796A (en) Rotor plane
GB2076691B (en) Impact-mill rotor
JPS56150960A (en) Generator
GB2368215B (en) Ranging
BG31627A1 (en) Power amplifyier
DE3276585D1 (en) Turbine
PHUM5259Z (en) Improved windmill